...
首页> 外文期刊>Global Advances in Health and Medicine >Homeopathic Medications as Clinical Alternatives for Symptomatic Care of Acute Otitis Media and Upper Respiratory Infections in Children:
【24h】

Homeopathic Medications as Clinical Alternatives for Symptomatic Care of Acute Otitis Media and Upper Respiratory Infections in Children:

机译:顺势疗法药物作为儿童急性中耳炎和上呼吸道感染的症状治疗的临床替代品:

获取原文

摘要

The public health and individual risks of inappropriate antibiotic prescribing and conventional over-the-counter symptomatic drugs in pediatric treatment of acute otitis media (AOM) and upper respiratory infections (URIs) are significant. Clinical research suggests that over-the-counter homeopathic medicines offer pragmatic treatment alternatives to conventional drugs for symptom relief in children with uncomplicated AOM or URIs. Homeopathy is a controversial but demonstrably safe and effective 200-year-old whole system of complementary and alternative medicine used worldwide. Numerous clinical studies demonstrate that homeopathy accelerates early symptom relief in acute illnesses at much lower risk than conventional drug approaches. Evidence-based advantages for homeopathy include lower antibiotic fill rates during watchful waiting in otitis media, fewer and less serious side effects, absence of drug-drug interactions, and reduced parental sick leave from work. Emerging evidence from basic and preclinical science research counter the skeptics’ claims that homeopathic remedies are biologically inert placebos. Consumers already accept and use homeopathic medicines for self care, as evidenced by annual US consumer expenditures of $2.9 billion on homeopathic remedies. Homeopathy appears equivalent to and safer than conventional standard care in comparative effectiveness trials, but additional well-designed efficacy trials are indicated. Nonetheless, the existing research evidence on safety supports pragmatic use of homeopathy in order to “first do no harm” in the early symptom management of otherwise uncomplicated AOM and URIs in children.
机译:在小儿急性中耳炎(AOM)和上呼吸道感染(URIs)的儿科治疗中,不适当的抗生素处方和常规的非处方对症药物的公共卫生和个人风险非常重要。临床研究表明,对于没有并发症的AOM或URI的儿童,非处方顺势疗法药物可提供实用的治疗替代传统药物来缓解症状。顺势疗法是一个有争议的但证明安全有效的全球已有200年历史的补充和替代药物整个系统。大量临床研究表明,顺势疗法可加速急性疾病的早期症状缓解,其风险远低于传统药物治疗方法。顺势疗法的基于证据的优势包括在中耳炎的等待期间较低的抗生素填充率,越来越少的严重副作用,不存在药物相互作用以及减少父母的病假。基础和临床前科学研究的新证据反驳了怀疑论者的说法,即顺势疗法是生物惰性的安慰剂。消费者已经接受和使用顺势疗法药物进行自我护理,美国每年在顺势疗法方面的支出为29亿美元,就证明了这一点。在比较有效性试验中,顺势疗法似乎等效于常规标准护理,并且比传统标准护理更安全,但还指出了其他精心设计的有效性试验。尽管如此,有关安全性的现有研究证据支持对顺势疗法的务实使用,以便“早期不危害”儿童的其他复杂的AOM和URI的早期症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号